Sign in

CIK 0001867066 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Journey Medical Corp

Sign in to watch
Ticker
DERM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471879539
Phone
480-434-6670
Business address
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ, 85258
  1. 4 Grant or award Director acquired 27,472 shares (grant or award)
  2. 4 Open-market sale President & CEO sold 20,767 shares at $1.76 ($36,550)
  3. 4 Open-market sale See Remarks sold 4,072 shares at $1.76 ($7,167)
  4. 4 Open-market sale President & CEO sold 44,377 shares at an average $1.30 ($57,665)
  5. 4/A Open-market sale See Remarks sold 10,093 shares at $2.41 ($24,324)
  6. 4 Open-market sale Interim CFO sold 2,768 shares at $1.97 ($5,453)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Chief Financial Officer sold 10,093 shares at $2.41 ($24,324)
  9. 4 Grant or award Director acquired 14,245 shares (grant or award)
  10. 4 Grant or award Director acquired 14,245 shares (grant or award)
  11. 4 Grant or award Director acquired 14,245 shares (grant or award)
  12. 4 Grant or award Director acquired 14,245 shares (grant or award)
  13. 4 Grant or award Director acquired 14,245 shares (grant or award)
  14. 4 Grant or award President & CEO acquired 300,000 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 150,000 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 30,000 shares (grant or award)
  18. 4 Grant or award Director acquired 30,000 shares (grant or award)
  19. 4 Grant or award Director acquired 30,000 shares (grant or award)
  20. 4 Grant or award Director acquired 30,000 shares (grant or award)

Page 4 of 5 · 88 filings